Relevia 3 by NewtonEverett — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Tablet(s) Serving Size

75 Servings

Non-Nutrient/Non-Botanical Product Type

67% Evidence Coverage

Supplement Facts — Evidence Check

Glucosamine HCl

1500 mg

📊 Market median: 1000.0mg (1115 products) 📚 22 studies (Tier A: 0, B: 9)

This product: 1500mg

Chondroitin Sulfate

1200 mg

📊 Market median: 600.0mg (79 products) 📚 24 studies (Tier A: 0, B: 6)

This product: 1200mg

Methylsulphonylmethane

250 mg

Other Ingredients

Microcrystalline Cellulose Stabilisers Anticaking Agents

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (89% of products) Nutrient (16% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years)

Product Information

📋 Directions for Use

2 per day

Suggested Use: Take two (2) tablets daily with food.

⚠️ Warnings & Precautions

Warning: Consult a physician before using if pregnant, nursing or on medication.

Keep out of reach of children.

Do not use if safety seal is broken. Do not exceed suggested daily intake.

Allergen Warning: Contains shellfish (shrimp, crab) ingredients.

🧪 Formulation Notes

RELEVIA-3 combines the best of science and nature to support healthy joint function in active adults. 1) Glucosamine helps maintain healthy cartilage levels 2) Chondroitin is essential for joint fluid which helps support cartilage 3) MSM helps support the development of new cells and connective tissue

Vegan product

Glucosamine 1500mg Chondroitin 1200mg Plus MSM 250mg

Allergen Warning: Contains shellfish (shrimp, crab) ingredients.

Additional Information

Store in a cool, dry place.

Triple strength

Flexibility Comfort Mobility

#12467 - K16

Product Details

UPC / SKU 8 18423 02878 1

DSLD Entry Date 2018-02-23

Product Type Non-Nutrient/Non-Botanical

Form Tablet or Pill

Brand NewtonEverett

DSLD ID 82630

Data Updated 2026-04-11

Research Evidence

39 Research Sources

50 Avg Quality Score

20 Rct

9 Meta Analysis

4 Clinical Trial

3 Systematic Review

1 Regulatory Source

1 Openfda Safety

B Interventions for the management of temporomandibular joint osteoarthritis

Systematic Review The Cochrane database of systematic reviews 2012

PubMed DOI Cochrane

B Glucosamine therapy for treating osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2005

PubMed Cochrane

B Chondroitin for osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis

Meta Analysis Archives of orthopaedic and trauma surgery 2023

PubMed DOI

B Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

Rct The New England journal of medicine 2006

PubMed

B Oral Glucosamine in the Treatment of Temporomandibular Joint Osteoarthritis: A Systematic Review

Systematic Review International journal of molecular sciences 2023

PubMed DOI

B Scientific Opinion on glucosamine and joint health

Regulatory Source EFSA Journal 2009

DOI

B Clinical Efficacy and Safety of Chondroitin Combined with Glucosamine in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis

Meta Analysis Computational and mathematical methods in medicine 2022

PubMed DOI

B Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

Rct Annals of the rheumatic diseases 2016

PubMed DOI

B Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials

Meta Analysis Journal of orthopaedic surgery and research 2018

PubMed DOI

View all evidence for Glucosamine →